Page 23 - Mark Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Evotec SE reports results for the first quarter 2021 and provides corporate update SUCCESSFUL START TO 2021 WITH STRONG STRATEGIC POSITION AND LONG-TERM STRATEGY: ACTION PLAN 2025 'THE DATA-DRIVEN R&D AUTOBAHN TO CURES' GOOD PROGRESS WITHIN PRODUCT DEVELOPMENT PARTNERSHIPS AND CO-OWNED PORTFOLIO CONTINUED POSITIVE FINANCIAL PERFORMANCE; NO MATERIAL IMPACT THROUGH COVID-19 PANDEMIC Hamburg, Germany, 11 May 2021: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced the financial results and corporate updates for the first quarter 2021. ...

EVOTEC SE REPORTS RESULTS FOR THE FIRST QUARTER 2021 AND PROVIDES CORPORATE UPDATE DGAP-News: Evotec SE / Key word(s): Quarter Results/Quarterly / Interim Statement 11.05.2021 / 07:00   SUCCESSFUL START TO 2021 WITH STRONG STRATEGIC POSITION AND LONG-TERM STRATEGY: ACTION PLAN 2025 "THE DATA-DRIVEN R&D AUTOBAHN TO CURES" GOOD PROGRESS WITHIN PRODUCT DEVELOPMENT PARTNERSHIPS AND CO-OWNED PORTFOLIO CONTINUED POSITIVE FINANCIAL PERFORMANCE; NO MATERIAL IMPACT THROUGH COVID-19 PANDEMIC Hamburg, Germany, 11 May 2021: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX,...

AlleyWatch C2i Genomics C2i Genomics is provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations. Founded by Boris Oklander, C2i Genomics is backed by investors that include Casdin Capital, NFX, and The Mark Foundation for Cancer Research and is headquartered in New York. INDUSTRY:Health Care, Pharmaceutical

April 19, 2021 In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL). The results could help scientists better understand disease origin and progression in patients. The paper is published online today in the journal Molecular Cell. “Our findings are very exciting in the field of both autoimmune disease and cancer, as they illustrate how pathogenic cells can ‘mis-u...

Alliance for Cancer Gene Therapy Summit 2021 Features World Renowned Cancer Researchers Advancing Solid Tumor Breakthroughs Share Article James P. Allison, PhD, Carl H. June, MD and Siddhartha Mukherjee, MD Keynote April 29 Summit Nobel Laureate James P. Allison, PhD, Carl H. June, MD and Pulitzer-prize winning author Siddhartha Mukherjee, MD will be the keynote speakers at the virtual Alliance for Cancer Gene Therapy Summit It’s so rare to have the opportunity to hear from the world’s top cancer researchers, biotechs, investors and patients all in the same room ...